Results 331 to 340 of about 345,134 (373)

When Neonates Require Anesthesia for the Management of Airway-Related Problems. [PDF]

Cureus
Maio B, Silva M.
europepmc   +1 more source

Dexmedetomidine versus ketamine as adjuvants in external oblique intercostal plane block for post thoracotomy pain: a randomised trial. [PDF]

BMC Anesthesiol
Moharam SA, ElSharkawy MS, Abdelhamid AS, Abdelbadie A, Kohaf NA, El Rahman Elgaria MA, Attia A, Elkashef AM.   +7 more
europepmc   +1 more source

A model to simulate human cardio-respiratory responses to ketamine analgesia. [PDF]

Front Physiol
Kurian V, Jin X, Wallqvist A, Reifman J, Nagaraja S.   +4 more
europepmc   +1 more source

Overlap and Divergence in Ketamine and Lithium Response in Bipolar Disorder: A Scoping Review. [PDF]

Pharmaceuticals (Basel)
Toulany J, Cunningham JEA, Nunes A.
europepmc   +1 more source

Rapid Improvement in Consciousness After Low-Dose Ketamine in a Patient With Acute Confusion: A Case Report. [PDF]

Cureus
Khalid WKK, Ibrahim HAM, Al Hoqani IAA.
europepmc   +1 more source

Serial Ketamine Infusions as Adjunctive Therapy to Inpatient Care for Depression: The KARMA-Dep 2 Randomized Clinical Trial.

JAMA Psychiatry
Jelovac A, McCaffrey C, Terao M, Shanahan E, Whooley E, McDonagh K, McDonogh S, Loughran O, Shackleton E, Igoe A, Thompson S, Mohamed E, Nguyen D, O'Neill C, Walsh C, McLoughlin DM.   +15 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression.

New England Journal of Medicine, 2023
BACKGROUND Electroconvulsive therapy (ECT) and subanesthetic intravenous ketamine are both currently used for treatment-resistant major depression, but the comparative effectiveness of the two treatments remains uncertain.
A. Anand, S. Mathew, G. Sanacora, J. Murrough, F. Goes, Murat Altinay, Amy Aloysi, A. Asghar-Ali, B. Barnett, Lee C Chang, K. Collins, S. Costi, Sidra Iqbal, M. Jha, K. Krishnan, D. Malone, Sina Nikayin, S. Nissen, R. Ostroff, I. Reti, S. Wilkinson, K. Wolski, Bo Hu   +22 more
semanticscholar   +1 more source

Why ketamine

Epilepsy & Behavior, 2023
We present the rationale for testing ketamine as an add-on therapy for treating benzodiazepine refractory (established) status epilepticus. In animal studies, ketamine terminates benzodiazepine refractory status epilepticus by interfering with the pathophysiological mechanisms and is a neuroprotectant.
Lisa, Coles, Eric S, Rosenthal, Thomas P, Bleck, Jordan, Elm, Shahriar, Zehtabchi, James, Chamberlain, James, Cloyd, Shlomo, Shinnar, Robert, Silbergleit, Jaideep, Kapur   +9 more
openaire   +2 more sources